RE: LeoThread 2024-10-12 10:21

[taskmaster4450le]

Commercialization Strategies

Flow Neuroscience's Approach

Flow has adopted a dual strategy:

1. B2C (Business-to-Consumer):

   • Initially selling directly to consumers in Europe
   • Obtained CE mark under European medical device rules
   • Provides revenue to fund further development and clinical trials

2. B2B (Business-to-Business):

   • Long-term goal to become a reimbursable medical device
   • Pilot programs with the UK's National Health Service (NHS)
   • Working towards FDA approval in the United States